section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

None significant.

Interactions

Drug-drug:

  • None reported.

Availability

(Generic available)
  • Chewable tablets: 40 mgOTC; 80 mgOTC; 125 mgOTC; 150 mgOTC
  • Tablets: 60 mgOTC; 80 mgOTC; 95 mgOTC
  • Capsules: 125 mgOTC; 166 mgOTC; 180 mgOTC; 250 mgOTC
  • Drops: 40 mg/0.6 mLOTC; 40 mg/mLOTC; 95 mg/1.425 mLOTC
  • In combination with:
  • antacidsOTC. See Combination Drugs.

Route/Dosage

  • PO (Adults ): 40–125 mg 4 times daily, after meals and at bedtime (up to 500 mg/day).
  • PO (Children 2–12 yr): 40 mg 4 times daily.
  • PO (Children <2 yr): 20 mg 4 times daily (up to 240 mg/day).

US Brand Names

Degas, Extra Strength Gas-X, Flatulex, Gas-X, Genasyme, Maximum Strength Mylanta Gas, Mylanta Gas, Mylicon, Phazyme

Action

  • Causes the coalescence of gas bubbles.
  • Does not prevent the formation of gas.
Therapeutic effects:
  • Passage of gas through the GI tract by belching or passing flatus.

Classifications

Therapeutic Classification: antiflatulent

Pharmacokinetics

Absorption: No systemic absorption occurs.

Distribution: Not systemically distributed.

Metabolism/Excretion: Excreted unchanged in the feces.

Half-Life: Unknown.

Canadian Brand Names

Gas Relief, Infacol, Ovol, Pediacol

Time/Action Profile

( antiflatulent effect)

ROUTEONSETPEAKDURATION
POimmediateunknown3 hr

Patient/Family Teaching

  • Explain purpose and side effects of medication, and the importance of diet and exercise in gas prevention. Advise patient to read Patient Information before starting therapy.
  • Advise patient to notify health care provider if symptoms persist.
  • Advise patient to notify health care provider of all Rx or OTC medications, vitamins, or herbal products being taken and to consult health care provider before taking other medications.

Pronunciation

si-METH-i-kone

Code

NDC Code